Details for New Drug Application (NDA): 207096
✉ Email this page to a colleague
NDA 207096 describes SODIUM PHENYLACETATE AND SODIUM BENZOATE, which is a drug marketed by Ailex Pharms Llc, Maia Pharms Inc, and Navinta Llc, and is included in five NDAs. It is available from five suppliers. Additional details are available on the SODIUM PHENYLACETATE AND SODIUM BENZOATE profile page.
The generic ingredient in SODIUM PHENYLACETATE AND SODIUM BENZOATE is sodium benzoate; sodium phenylacetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.
The generic ingredient in SODIUM PHENYLACETATE AND SODIUM BENZOATE is sodium benzoate; sodium phenylacetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.
Summary for 207096
| Tradename: | SODIUM PHENYLACETATE AND SODIUM BENZOATE |
| Applicant: | Ailex Pharms Llc |
| Ingredient: | sodium benzoate; sodium phenylacetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10%;10% (5GM/50ML;5GM/50ML) | ||||
| Approval Date: | Feb 24, 2016 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
